|
Group
|
Baseline
|
Week 1
|
Week 2
|
Week 4
|
Week 6
|
Week 8
|
|---|
|
Placebo
|
72.9 ± 2.1
|
71.4 ± 2.7
|
68.4 ± 3.2
|
63.9 ± 3.3 **
|
58.6 ± 3.9 **
|
52.0 ± 4.7 ***
|
|
A
|
72.9 ± 3.0
|
66.8 ± 3.3
|
62.5 ± 4.7 **
|
51.2 ± 5.0 ***
|
49.7 ± 5.1 ***
|
42.7 ± 5.2 ***
|
|
B
|
70.1 ± 2.5
|
65.8 ± 3.2
|
58.9 ± 3.8 **
|
52.0 ± 4.7***
|
51.9 ± 5.0 ***
|
44.6 ± 4.9 ***
|
|
C
|
70.7 ± 2.4
|
65.0 ± 2.6
|
60.7 ± 2.9 **
|
52.7 ± 2.5 ***
|
47.2 ± 3.4 ***
|
43.4 ± 3.8 ***
|
- Data expressed as mean ± sem. Group A = High dose sierrasil (n = 20), Group B = Low dose sierrasil (n = 21), Group C = Low dose sierrasil + cat's claw extract (n = 25), placebo n = 22. All groups displayed a significant change over the 8 weeks of the study (p < 0.001, ANOVA). Using a Wilcoxan matched pairs Signed-Rank test from baseline; * p < 0.05, ** p < 0.01, *** p < 0.001.
